Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120
Keywords: سندرم اسید رتینوئیک; AML; Isocitrate dehydrogenase mutation; Myeloid maturation; Retinoic acid syndrome; Targeted therapy